Emergent BioSolutions, Inc. (EBS)
12.16
-0.06
(-0.49%)
USD |
NYSE |
Dec 30, 16:00
12.03
-0.13
(-1.07%)
Pre-Market: 20:00
Emergent BioSolutions EPS Diluted (Quarterly): 0.9062 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Black Diamond Therapeutics, Inc. | -0.1493 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 51.20M |
| Revenue (Quarterly) | 231.10M |
| Total Expenses (Quarterly) | 179.90M |
| Enterprise Value | 1.060B |
| Gross Profit Margin (Quarterly) | 55.86% |
| Profit Margin (Quarterly) | 22.15% |
| Earnings Yield | 10.64% |
| Operating Earnings Yield | 17.17% |
| Normalized Earnings Yield | 10.38 |